Evgen Pharma (EVG)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

4.48p
   
  • Change Today:
    -0.070p
  • 52 Week High: 7.10
  • 52 Week Low: 2.85
  • Currency: UK Pounds
  • Shares Issued: 274.89m
  • Volume: 162,912
  • Market Cap: £12.31m
  • RiskGrade: 304

Evgen Pharma Overview

Evgen is a clinical stage drug development company focused on the development of sulforaphane-based compounds, a new class of pharmaceuticals which are synthesised in a proprietary, well-tolerated, stable formulation.

1 Day Chart

1 Day Chart

6 Month Chart

6 Month Chart
Barclays logo

Digital Look Charts Sponsored by Barclays Stockbrokers

Financials

Latest F'cast
Div Yield 0.0% 0.0%
Div Cover n/a n/a
Op Mrgn n/a -780.0%
ROCE n/a  
Latest F'cast
P/E n/a n/a
PEG n/a n/a
Pr/Revenue n/a 25.0
Pr/Book 1.4  
Latest F'cast
Revenue n/a n/a
PBT n/a n/a
EPS n/a n/a
DPS n/a n/a

Evgen Pharma Fundamentals

Year Ending Revenue (£m) Pre-tax (£m) EPS P/E PEG EPS Grth. Div Yield
31-Mar-18 n/a (3.03) (3.23)p n/a n/a n/a n/a 0.0%
31-Mar-19 n/a (3.12) (2.70)p n/a n/a n/a n/a 0.0%
31-Mar-20 n/a (3.17) (2.07)p n/a n/a n/a n/a 0.0%
31-Mar-21 0.19 (3.21) (1.82)p n/a n/a n/a n/a 0.0%
31-Mar-22 n/a (3.17) (0.99)p n/a n/a n/a n/a 0.0%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

Evgen Pharma Forecasts

Year Ending Revenue (£m) Pre-tax (£m) EPS P/E PEG EPS Grth. Div Yield
31-Mar-23 0.50 (3.90) (1.20)p n/a n/a n/a n/a 0.0%
31-Mar-24 5.00 (1.60) (0.20)p n/a n/a n/a n/a 0.0%

Copyright © 2023 FactSet Research Systems Inc. All rights reserved.

Evgen Pharma Company Announcements

Clinical trial update 25-Jan-2023 07:00 RNS
Grant of Options - Director/PDMR Shareholding 14-Dec-2022 17:08 RNS
Half-year Report 08-Dec-2022 07:00 RNS

Evgen Pharma ShareCast News

Evgen Pharma doses first volunteers in SFX-01 tr... 16-Nov-2022 ShareCast
Evgen starts recruiting volunteers for trial of ... 12-Oct-2022 ShareCast
Evgen agrees fresh licensing deal with Spanish i... 18-Jan-2022 ShareCast

Latest Evgen Pharma Director Deals

No deals were found in the last 28 days.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 4: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 5: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 6: Forecast figures based on normalised accounts.

 

Evgen Pharma Market Data

Currency UK Pounds
Share Price 4.48p
Change Today -0.070p
% Change -1.54 %
52 Week High 7.10
52 Week Low 2.85
Volume 162,912
Shares Issued 274.89m
Market Cap £12.31m
RiskGrade 304

Evgen Pharma Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
12.35% below the market average12.35% below the market average12.35% below the market average12.35% below the market average12.35% below the market average
51.72% above the sector average51.72% above the sector average51.72% above the sector average51.72% above the sector average51.72% above the sector average
Price Trend
12.94% above the market average12.94% above the market average12.94% above the market average12.94% above the market average12.94% above the market average
48.39% above the sector average48.39% above the sector average48.39% above the sector average48.39% above the sector average48.39% above the sector average
Income Not Available
Growth Not Available

Evgen Pharma Dividends

No dividends found

Trades for 06-Feb-2023

Time Volume / Share Price
08:32 50,000 @ 4.55p
08:28 212 @ 4.70p
08:28 100 @ 4.30p
08:27 2,600 @ 4.40p
08:24 50,000 @ 4.43p

Evgen Pharma Key Personnel

CFO Richard Moulson
CEO Huw Jones

Top of Page